Global insurance giant Prudential signed an exclusive agreement to use Babylon Health’s artificial intelligence (AI) based healthcare application for five million existing and new
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh